Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

SEC Filing · 4

CTT PHARMACEUTICAL HOLDINGS, INC.

CTTHOTCEQUITYCurrent

SEC Filing

Filed Sep 22, 2026Accepted Sep 22, 2026, 10:15 AM EDTCIK 1035422Accession 0001035422-26-000013
Share

Company context

CTT Pharmaceutical Holdings, Inc. is a pharmaceutical technology company specializing in oral drug delivery systems designed to provide rapid onset, enhanced patient convenience, and efficient absorption. The Company’s patented micelle based thin film platform is intended to offer a novel alternative to traditional dosage forms across pharmaceutical, therapeutic, and nutraceutical markets. CTT is focused on integrating scientific validation, scalable manufacturing, and regulatory preparedness to support long-term growth and product innovation.

Current securities

Recent company filings

  1. Entry into a Material Definitive Agreement · Other EventsSep 23, 2026
  2. 10-Q filingSep 17, 2026
  3. 4 filingSep 16, 2026
  4. 4 filingSep 10, 2026
  5. 4 filingSep 4, 2026

As-filed source

Primary evidence